26.1% CAGR Anticipated for Connected Drug Delivery Devices Market During the Forecast Period 2018 to 2026

Connected Drug Delivery Devices Market

Acumen Research and Consulting has announced the addition of the “Connected Drug Delivery Devices Market” report to their offering.

The Connected Drug Delivery Devices Market Industry Report 2018 is an in depth study analyzing the current state of the Connected Drug Delivery Devices Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Connected Drug Delivery Devices Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Connected Drug Delivery Devices Market also discusses the opportunity areas for investors.

Introduction

The Global Connected Drug Delivery Devices Market is project worth $718.9 Billion in 2026 and the market is projected to showcase 26.1% CAGR during the forecast period. The market is driven by increasing penetration of Internet of Things (IoT) in healthcare sector.

Market Dynamics

Increase in acceptance to technology in healthcare sector is the key reason for the growth of the connected drug delivery devices market. Also, supportive government regulation for healthcare sector is positively impacting the growth of the industry and is expected to push the growth during the forecast period.

Connected drug delivery devices technological innovation that has bridged the unsought gap between healthcare and digital technology. The emergence of these ‘healthcare-cum-technology’ devices have addressed the soaring need for better diagnostics and targeted therapeutic tools. It has outpaced the conventional endoscopy by more convenient capsule endoscopy technology, which has now become the standard for non-invasive diagnosis of motility disorders. Moreover, it not only helps physicians in real-time patient monitoring through remote controlling options, but also works as a dose reminder for the patients. Recent success in targeted drug delivery for diseases such as Crohn’s disease, Colitis and Colon cancer has opened new avenues for connected drug delivery devices.

Market Insights

The global connected drug delivery devices market is expected to register substantial growth in the near future, attributed to an increased collaborations between research institutions and companies, licensing agreements and partnerships amongst companies and augmented R&D investment on connected drug delivery devices. Other factors that drive the connected drug delivery devices market are rising prevalence of motility disorders, colon cancer, sedentary lifestyle, encouraging reimbursement environment, high patient compliance due to minimally invasive techniques, targeted drug delivery, and remote patient monitoring. However, factors such as high costs, limited technical knowledge and the patient’s expectations are likely to restrain the growth of the market.

Market Classification

The global connected drug delivery devices market is segmented into four major segment named product, end-user, technology, and region. On the basis of product the connected drug delivery devices market is segmented into connected sensors and integrated connected devices. These connected sensors are further bifurcated into inhaler sensors and injection sensors, and the integrated connected devices is also further segmented into integrated inhaler, and integrated injection. On the basis of the end-user the global connected drug delivery devices market is segmented into healthcare providers and homecare centers. On the basis of technology, the connected drug delivery devices market is segmented into bluetooth, NFC, other technologies (cellular, low power wide area network) On the basis of region the global connected drug delivery devices market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Regional Insights

In 2017, North America captured largest revenue share and the region is projected to continue its dominance over the forecast period as the region is highly active towards the adoption of modern technology. Other reason for the growth of the North America connected drug delivery market are high per capita healthcare expenditure, and increasing awareness about the adverse effects of non-adherence to medication.

Europe is projected to be the second fastest-developing market for connected drug delivery devices. Augmented incidence of chronic diseases and incidence of a huge target population base are the key parameter increasing demand for connected drug delivery devices in the region. Asia Pacific, Latin America, and Middle East and Africa, the need for connected drug delivery devices is anticipated to remain low during forecast period. This is due to less awareness of better healthcare facilities.

Download Sample Report Copy@ https://www.acumenresearchandconsulting.com/request-sample/910

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Report Coverage:

Market	Connected Drug Delivery Devices Market
Analysis Period	2016 – 2026
Historic Data	2016 – 2017
Base Year	2018
Forecast Data	2019 – 2026
Market Stratification	Product, End-user, Technology  and Geography
Regional Scope	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)
Report Coverage	Market Trends, Drivers, Restraints, Porter’s Five Forces Analysis, Competitive Analysis, Player Profiling, Value Chain Analysis

View Detail Report@ https://www.acumenresearchandconsulting.com/connected-drug-delivery-devices-market

Market Players:

Proteus Digital Health, Propeller Health, Merck, Adherium, and BIOCORP

The Major Market Segments of Global Connected Drug Delivery Devices Market are as below:

Market By Product

• Connected Sensors
  • Inhaler Sensors
  • Injection Sensors
• Integrated Connected Devices
  • Integrated Inhaler
  • Integrated Injection

Market By Technology

• Bluetooth
• NFC
• Other Technologies (Cellular, Low Power Wide Area Network)

Market By End-user

• Healthcare Providers
• Homecare Centers

Market By Geography

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • UK
  • Germany
  • France
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America

• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Rest of MEA

Table of Content

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope

1.1.1. Definition of Connected Drug Delivery Devices

1.1.2. Market Segmentation

1.1.3. List of Abbreviations

1.2. Summary

1.2.1. Market Snapshot

1.2.2. Connected Drug Delivery Devices Market By Product

1.2.2.1. Global Connected Drug Delivery Devices Market Revenue and Growth Rate Comparison By Product (2015-2026)

1.2.2.2. Global Connected Drug Delivery Devices Market Revenue Share By Product in 2017

1.2.2.3. Connected Sensors

1.2.2.4. Integrated Connected Devices

1.2.2.5. Others

1.2.3. Connected Drug Delivery Devices Market By Technology

1.2.3.1. Global Connected Drug Delivery Devices Market Revenue and Growth Rate Comparison By Technology (2015-2026)

1.2.3.2. Bluetooth

1.2.3.3. NFC

1.2.3.4. Other Technologies

1.2.4. Connected Drug Delivery Devices Market By End Users

1.2.4.1. Global Connected Drug Delivery Devices Market Revenue and Growth Rate Comparison By End Users (2015-2026)

1.2.4.2. Healthcare Providers

1.2.4.3. Homecare Centers

1.2.4.4. Others

1.2.5. Connected Drug Delivery Devices Market by Geography

1.2.5.1. Global Connected Drug Delivery Devices Market Revenue and Growth Rate Comparison by Geography (2015-2026)

1.2.5.2. North America Connected Drug Delivery Devices Market Revenue and Growth Rate (2015-2026)

1.2.5.3. Europe Connected Drug Delivery Devices Market Revenue and Growth Rate (2015-2026)

1.2.5.4. Asia-Pacific Connected Drug Delivery Devices Market Revenue and Growth Rate (2015-2026)

1.2.5.5. Latin America Connected Drug Delivery Devices Market Revenue and Growth Rate (2015-2026)

1.2.5.6. Middle East and Africa (MEA) Connected Drug Delivery Devices Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers

2.2. Restraints and Challenges

2.3. Growth Opportunities

2.4. Porter’s Five Forces Analysis

2.4.1. Bargaining Power of Suppliers

2.4.2. Bargaining Power of Buyers

2.4.3. Threat of Substitute

2.4.4. Threat of New Entrants

2.4.5. Degree of Competition

2.5. Value Chain Analysis

2.6. Cost Structure Analysis

2.6.1. Raw Material and Suppliers

2.6.2. Manufacturing Process Analysis

2.7. Regulatory Compliance

2.8. Competitive Landscape, 2017

2.8.1. Player Positioning Analysis

2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Homecare Centers Production Date of Global Connected Drug Delivery Devices Major Manufacturers in 2017

3.2. Manufacturing Plants Distribution of Global Connected Drug Delivery Devices Major Manufacturers in 2017

3.3. R&D Status and Technology Source of Global Connected Drug Delivery Devices Major Manufacturers in 2017

3.4. Raw Materials Sources Analysis of Global Connected Drug Delivery Devices Major Manufacturers in 2017

CHAPTER 4. CONNECTED DRUG DELIVERY DEVICES MARKET BY PRODUCT

4.1. Global Connected Drug Delivery Devices Revenue By Product

4.2. Connected Sensors

4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

4.3. Integrated Connected Devices

4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

4.4. Other

4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. CONNECTED DRUG DELIVERY DEVICES MARKET BY TECHNOLOGY

5.1. Global Connected Drug Delivery Devices Revenue By Technology

5.2. Bluetooth

5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

5.3. NFC

5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

5.4. Other Technologies

5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. CONNECTED DRUG DELIVERY DEVICES MARKET BY END USERS

6.1. Global Connected Drug Delivery Devices Revenue By End Users

6.2. Healthcare Providers

6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

6.3. Homecare Centers

6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

6.4. Others

6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)

6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY

7.1. North America Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 – 2026 ($Million)

7.2. North America Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)

7.3. U.S.

7.3.1. U.S. Connected Drug Delivery Devices Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

7.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

7.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

7.4. Canada

7.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

7.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

7.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

7.5. Mexico

7.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

7.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

7.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 8. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY

8.1. Europe Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 – 2026 ($Million)

8.2. Europe Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)

8.3. UK

8.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

8.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

8.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

8.4. Germany

8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

8.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

8.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

8.5. France

8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

8.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

8.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

8.6. Spain

8.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

8.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

8.6.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

8.7. Rest of Europe

8.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

8.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

8.7.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY

9.1. Asia-Pacific Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 – 2026 ($Million)

9.2. Asia-Pacific Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)

9.3. China

9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

9.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

9.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

9.4. Japan

9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

9.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

9.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

9.5. India

9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

9.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

9.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

9.6. Australia

9.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

9.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

9.6.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

9.7. South Korea

9.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

9.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

9.7.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

9.8. Rest of Asia-Pacific

9.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

9.8.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

9.8.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 10. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY 

10.1. Latin America Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 – 2026 ($Million)

10.2. Latin America Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)

10.3. Brazil

10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

10.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

10.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

10.4. Argentina

10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

10.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

10.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

10.5. Rest of Latin America

10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

10.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

10.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 11. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY 

11.1. Middle East Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 – 2026 ($Million)

11.2. Middle East Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)

11.3. Saudi Arabia

11.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

11.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

11.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

11.4. UAE

11.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

11.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

11.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

11.5. Rest of Middle East

11.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

11.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

11.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 12. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY 

12.1. Africa Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 – 2026 ($Million)

12.2. Africa Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)

12.3. South Africa

12.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

12.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

12.3.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

12.4. Egypt

12.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

12.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

12.4.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

12.5. Rest of Africa

12.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)

12.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

12.5.3. Market Revenue and Forecast By End Users, 2015 – 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Proteus Digital Health

13.1.1. Company Snapshot

13.1.2. Overview

13.1.3. Financial Overview

13.1.4. Type Portfolio

13.1.5. Key Developments

13.1.6. Strategies

13.2. Propeller Health

13.2.1. Company Snapshot

13.2.2. Overview

13.2.3. Financial Overview

13.2.4. Type Portfolio

13.2.5. Key Developments

13.2.6. Strategies

13.3. Merck

13.3.1. Company Snapshot

13.3.2. Overview

13.3.3. Financial Overview

13.3.4. Type Portfolio

13.3.5. Key Developments

13.3.6. Strategies

13.4. Adherium

13.4.1. Company Snapshot

13.4.2. Overview

13.4.3. Financial Overview

13.4.4. Type Portfolio

13.4.5. Key Developments

13.4.6. Strategies

13.5. BIOCORP

13.5.1. Company Snapshot

13.5.2. Overview

13.5.3. Financial Overview

13.5.4. Type Portfolio

13.5.5. Key Developments

13.5.6. Strategies

13.6. Others

13.6.1. Company Snapshot

13.6.2. Overview

13.6.3. Financial Overview

13.6.4. Type Portfolio

13.6.5. Key Developments

13.6.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology

14.1.1. Initial Data Search

14.1.2. Secondary Research

14.1.3. Primary Research

14.2. Assumptions and Scope

Ask Query Here: frank@acumenresearchandconsulting.com  or sales@acumenresearchandconsulting.com

To Purchase this Premium Report@  https://www.acumenresearchandconsulting.com/buy-now/0/910

About Us:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Share this: